HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action

Por Imai, Yoichi, Hirano, Mitsuhito, Kobayashi, Masayuki, Futami, Muneyoshi, Tojo, Arinobu
Publicado no Cancers (Basel) (2019)

Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma

Por Futami, Muneyoshi, Sato, Kota, Miyazaki, Kanji, Suzuki, Kenshi, Nakamura, Takafumi, Tojo, Arinobu
Publicado no Mol Ther Oncolytics (2017)

The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells

Por Futami, Muneyoshi, Suzuki, Keisuke, Kato, Satomi, Ohmae, Saori, Tahara, Yoshio, Nojima, Masanori, Imai, Yoichi, Mimura, Takayuki, Watanabe, Yoshihiro, Tojo, Arinobu
Publicado no PLoS One (2020)

G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase

Por Futami, Muneyoshi, Zhu, Quan-sheng, Whichard, Zakary L., Xia, Ling, Ke, Yuehai, Neel, Benjamin G., Feng, Gen-Sheng, Corey, Seth J.
Publicado em 2011

DASATINIB INHIBITS THE GROWTH OF MOLECULARLY HETEROGENEOUS MYELOID LEUKEMIAS

Por Guerrouahen, Bella S., Futami, Muneyoshi, Vaklavas, Christos, Kanerva, Jukka, Whichard, Zakary L., Nwawka, Kenechi, Blanchard, Elisabeth G., Lee, Francis Y., Robinson, Lisa J., Arceci, Robert, Kornblau, Steven M., Wieder, Eric, Cayre, Yvon E., Corey, Seth J.
Publicado em 2010

Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma

Por Hirano, Mitsuhito, Imai, Yoichi, Kaito, Yuta, Murayama, Takahiko, Sato, Kota, Ishida, Tadao, Yamamoto, Junichi, Ito, Takumi, Futami, Muneyoshi, Ri, Masaki, Yasui, Hiroshi, Denda, Tamami, Tanaka, Yukihisa, Ota, Yasunori, Nojima, Masanori, Kamikubo, Yasuhiko, Gotoh, Noriko, Iida, Shinsuke, Handa, Hiroshi, Tojo, Arinobu
Publicado no J Exp Clin Cancer Res (2021)